The activation of these pathways leads to upregulation and secretion of several cytokines and factors from both MM and BMM cells such as interleukin-6 (IL-6), insulin-like growth factor-1, VEGF, tumor necrosis factor alpha (TNF-α), and transforming growth factor-β [11,12]. This evidence concerns the gene IL6 and Miyoshi myopathy.